Efalizumab-induced thrombocytopenia: Report of relapse after re-administration

Clinical and Experimental Dermatology

Volumn 34, Issue 8, 2009, Pages

  Kiorpelidou, D ^a   Tsiouri, G ^a   Gaitanis, G ^a   Akritidis, N ^b   Bassukas, I D ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB; INFLIXIMAB; METHYLPREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; HUMAN; LABORATORY; MALE; PRIORITY JOURNAL; PSORIASIS; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL; DRUG ERUPTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; RECURRENCE; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 72549114377     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03697.x     Document Type: Article

References (6)

1. Lebwohl M, Bagel J, Gelfand JM et al. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol 2008 58 : 94 105.
2. Warkentin TE, Kwon P. Immune thrombocytopenia associated with efalizumab therapy for psoriasis. Ann Intern Med 2005 143 : 761 763.
3. Platelets on the Web. http://www.ouhsc.edu/platelets/ (accessed 17 July 2009).
4. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007 357 : 580 587.
5. Diacovo TG, deFougerolles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2. J Clin Invest 1994 94 : 1243 1251.
6. Kojouri K, Vesely S, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. frequency, clinical features, and long-term outcomes. Ann Intern Med 2001 135 : 1047 1051.